FDA-approved polypeptide PTH 1–34 impedes palmitic acid-mediated osteoblasts dysfunction by promoting its differentiation and thereby improving skeletal health
Molecular and Cellular Endocrinology · 2025
DOI: 10.1016/j.mce.2024.112445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2025. Verfasst von Anirban Sardar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, UP, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad…. Hauptthemen laut MEDLINE: Osteoblasts, Cell Differentiation, Palmitic Acid, Parathyroid Hormone. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, University Grants Commission.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, UP, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
- Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, UP, India.
- Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, UP, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. Electronic address: ritu_trivedi@cdri.res.in.
Förderung
- Council of Scientific and Industrial Research, India
- University Grants Commission
Zitieren
APA
Sardar, A., Rai, D., Tripathi, A. K., Chutani, K., Sinha, S., Dhaniya, G., & Trivedi, R. (2025). FDA-approved polypeptide PTH 1–34 impedes palmitic acid-mediated osteoblasts dysfunction by promoting its differentiation and thereby improving skeletal health. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2024.112445
Vancouver
Sardar A, Rai D, Tripathi AK, Chutani K, Sinha S, Dhaniya G, et al. FDA-approved polypeptide PTH 1–34 impedes palmitic acid-mediated osteoblasts dysfunction by promoting its differentiation and thereby improving skeletal health. Molecular and Cellular Endocrinology. 2025. doi:10.1016/j.mce.2024.112445
BibTeX
@article{Sardar2025,
author = {Sardar, Anirban and Rai, Divya and Tripathi, Ashish Kumar and Chutani, Kunal and Sinha, Shradha and Dhaniya, Geeta and Trivedi, Ritu},
title = {FDA-approved polypeptide PTH 1–34 impedes palmitic acid-mediated osteoblasts dysfunction by promoting its differentiation and thereby improving skeletal health},
journal = {Molecular and Cellular Endocrinology},
year = {2025},
doi = {10.1016/j.mce.2024.112445}
}
EUVIMED